| NCT ID | NCT07495332 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Duke University |
| Condition | Fatty Liver |
| Study Type | INTERVENTIONAL |
| Enrollment | 45 participants |
| Start Date | 2026-03-27 |
| Primary Completion | 2027-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 45 participants in total. It began in 2026-03-27 with a primary completion date of 2027-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to see how well Photon Counting CT (PCCT) and ultrasound test results can find fat and scarring in the liver. They will be compared to MRI test results as the reference standard. Participants will get a regular CT scan on the PCCT scanner, plus a few extra pictures just for the study. They will also get an MRI, either on the same day or a different day, whichever is preferred. Participants will get an ultrasound on the same day as the MRI. If they have not had a hematocrit blood test in the past 24 hours, they will also receive one on the day of the CT scan.
Eligibility Criteria
Inclusion Criteria: * Age of 18 years or older * Has clinically indicated CT schedule including the liver (with contrast or with and without contrast) * Patient eligible for MR imaging * History of chronic diffuse liver disease, steatotic liver disease, and/ or liver fibrosis * Capable of consent Exclusion Criteria: * Contraindications to any of the required imaging examinations * BMI \> 45 (based on MRI scanner capacity)
Contact & Investigator
Mustafa Bashir, MD
PRINCIPAL INVESTIGATOR
Duke University
Frequently Asked Questions
Who can join the NCT07495332 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Fatty Liver. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07495332 currently recruiting?
Yes, NCT07495332 is actively recruiting participants. Contact the research team at mustafa.bashir@duke.edu for enrollment information.
Where is the NCT07495332 trial being conducted?
This trial is being conducted at Durham, United States.
Who is sponsoring the NCT07495332 clinical trial?
NCT07495332 is sponsored by Duke University. The principal investigator is Mustafa Bashir, MD at Duke University. The trial plans to enroll 45 participants.